[{"Assets_0_Q2_USD":1791098000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":74477000.0,"NetIncomeLoss_1_Q2_USD":46349000.0,"NetIncomeLoss_2_Q2_USD":89351000.0,"StockholdersEquity_0_Q2_USD":834950000.0,"EarningsPerShareBasic_1_Q2_USD":0.83,"EarningsPerShareBasic_2_Q2_USD":1.61,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":55536000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":55486000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20190807"}]